• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18688

【品名】3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline

【CA登记号】367-21-5

【 分 子 式 】C6H5ClFN

【 分 子 量 】145.5635432

【元素组成】C 49.51% H 3.46% Cl 24.36% F 13.05% N 9.62%

与该中间体有关的原料药合成路线共 14 条

合成路线1

该中间体在本合成路线中的序号:(I)

3-Chloro-4-fluoroaniline (I), condensed by heating at 125 C with diethyl ethoxymethylenemalonate (A), gives diethyl 3-chloro-4-fluoroanilinomethylenemalonate (II). The thermal cyclization of (II) by reflux in A Dowtherm gives ethyl 6-fluoro-7-chloro-4-hydroxyquinoline-3-carboxylate (III), which, alkylated by ethyliodide in DMF with potassium carbonate, leads to ethyl 1-ethyl-6 fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate (IV), purified by recrystallization. The ester (IV), after saponification and acidification, provides the corresponding acid (V). 1-Ethyl-6-fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (V), heated to 100 C in pyridine with 1-methylpiperazine (B), leads to 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (VI). The salification of (VI) with methanesulfonic acid provides the salt.

1 Pesson, M.; Montay, G.; Goueffon, Y.; Roquet, F.; Microbiologie: Sur un nouvel antibacterien de synthese:l¡Acide ethyl-2-fluoro-6-(methyl-4-piperazinyl-1)-oxo-4-dihydro-1,4-quinoleine-3-carboxylique (1589 RB). CR Acad Sci Paris 1981, 292.
2 Bellon, A.; Pefloxacin mesylate. Drugs Fut 1982, 7, 9, 646.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情
(A) 14088 Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate 87-13-8 C10H16O5 详情 详情
(I) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(II) 32073 Diethyl 2-[[(3-chloro-4-fluorophenyl)imino]methyl]malonate; Diethyl 3-chloro-4-fluoroanilinomethylenemalonate C14H15ClFNO4 详情 详情
(III) 32074 Ethyl 7-chloro-6-fluoro-4-hydroxy-1,4-dihydro-3-quinolinecarboxylate C12H11ClFNO3 详情 详情
(IV) 32075 ethyl 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate C14H13ClFNO3 详情 详情
(V) 32076 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid 68077-26-9 C12H9ClFNO3 详情 详情
(VI) 32077 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid C17H20FN3O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

Monodemethylation of 6,7-dimethoxyquinazolin-4(3H)-one (I) in refluxing methanesulfonic acid in the presence of L-methionine provides 6-hydroxy-7-methoxyquinazolin-4(3H)-one (II), which is acetylated with acetic anhydride and pyridine at 100 C to give the acetate (III). Treatment of compound (III) with refluxing SOCl2 and a catalytic amount of DMF yields chloride (IV), which by condensation with 3-chloro-4-fluoroaniline (V) in boiling isopropanol affords the anilinoquinazoline (VI). Hydrolysis of the acetate group of (VI) by treatment with NH4OH in refluxing MeOH gives the 6-hydroxyquinazoline derivative (VII), which finally is alkylated with 3-(4-morpholinyl)-propyl chloride (VIII) or 3-(4-morpholinyl)propyl bromide (IX).

1 Gibson, K.H.; Grundy, W.; Barker, A.J.; et al.; Studies leading to the identification of ZD1839 (Iressa(TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001, 11, 14, 1911.
2 D'Souza, N.; Castañer, J.; Levin, M.; Iressa. Drugs Fut 2002, 27, 4, 339.
3 Gibson, K.H. (AstraZeneca plc); Quinazoline derivs.. EP 0823900; JP 1999504033; US 5770599; WO 9633980 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18684 6,7-dimethoxy-4(3H)-quinazolinone 13794-72-4 C10H10N2O3 详情 详情
(II) 18685 6-hydroxy-7-methoxy-4(3H)-quinazolinone 179688-52-9 C9H8N2O3 详情 详情
(III) 18686 7-methoxy-4-oxo-3,4-dihydro-6-quinazolinyl acetate 179688-53-0 C11H10N2O4 详情 详情
(IV) 18687 4-chloro-7-methoxy-6-quinazolinyl acetate 230955-75-6 C11H9ClN2O3 详情 详情
(V) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VI) 18689 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl acetate 788136-89-0 C17H13ClFN3O3 详情 详情
(VII) 18690 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol 184475-71-6 C15H11ClFN3O2 详情 详情
(VIII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(IX) 52653 4-(3-bromopropyl)morpholine 125422-83-5 C7H14BrNO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

4-Chloro-7-fluoro-6-nitroquinazoline (I) was condensed with 3-chloro-4-fluoroaniline (II) to afford the 4-anilino quinazoline (III). Displacement of the activated fluorine of (III) with the potassium alkoxide of morpholinopropanol (IV) gave the morpholinopropyl ether (V). Subsequent reduction of the nitro group of (V), either using iron dust and acetic acid or catalytic hydrogenation over Raney-Ni, furnished aminoquinazoline (VI). This was finally condensed with acrylic acid (VII), via activation as the mixed anhydride with isobutyl chloroformate or using EDC as the coupling reagent, to provide the title acrylamide.

1 Loo, J.A.; Rewcastle, G.W.; Smaill, J.B.; et al.; Tyrosine kinase inhibitors.17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides baring additional solubilizing functions. J Med Chem 2000, 43, 7, 1380.
2 Bridges, A.J.; Klohs, W.D.; Driscoll, D. (Pfizer Inc.); N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases. EP 1131304; US 6344455; WO 0031048 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19142 4-chloro-7-fluoro-6-nitroquinazoline C8H3ClFN3O2 详情 详情
(II) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(III) 54956 N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-(7-fluoro-6-nitro-4-quinazolinyl)amine 162012-67-1 C14H7ClF2N4O2 详情 详情
(IV) 54957 3-(4-morpholinyl)-1-propanol C7H15NO2 详情 详情
(V) 54958 N-(3-chloro-4-fluorophenyl)-7-[3-(4-morpholinyl)propoxy]-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-{7-[3-(4-morpholinyl)propoxy]-6-nitro-4-quinazolinyl}amine C21H21ClFN5O4 详情 详情
(VI) 54959 N-{6-amino-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl}-N-(3-chloro-4-fluorophenyl)amine; N~4~-(3-chloro-4-fluorophenyl)-7-[3-(4-morpholinyl)propoxy]-4,6-quinazolinediamine C21H23ClFN5O2 详情 详情
(VII) 19139 acrylic acid 79-10-7 C3H4O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

The reaction of 5-bromo-2-(methylsulfanyl)pyrimidine-4-carboxylic acid (I) with ammonia and CuSO4 in water gives 5-amino-2-(methylsulfanyl)pyrimidine-4-carboxylic acid (II), which is cyclized with formamide or formamidine acetate by heating at 180 C to yield 4-hydroxy-6-(methylsulfanyl)pyrimido[5,4-d]pyrimidine (III). The reaction of (III) with refluxing SOCl2 affords the corresponding 4-chloro derivative (IV), which is condensed with 3-chloro-4-fluoroaniline (V) in hot dioxane to provide the secondary amine (VI). Alternatively, (VI) can also be obtained by direct condensation of the 4-hydroxy compound (III) with aniline (V) by means of HMDS and Ts-OH at 140 ?C. The oxidation of the sulfanyl group of (VI) with MCPBA in dichloromethane provides a mixture of the sulfinyl derivative (VII) and the sulfonyl derivative (VIII), which, without isolation, is finally condensed with 1-methylpiperidin-4-amine (IX) by means of DIEA in hot DMF to give the target pyrimido-pyrimidine-diamine.

1 Himmelsbach, F.; Dahmann, G.; von Rüden, T.; Metz, T. (Dr. Karl Thomae GmbH); Pyrimido[5,4-d]pyrimidines, medicaments containing these cpds., their use and process for their production. DE 19608588; EP 0888351; JP 2000506151; US 5821240; WO 9732880 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54678 5-bromo-2-(methylsulfanyl)-4-pyrimidinecarboxylic acid C6H5BrN2O2S 详情 详情
(II) 54679 5-amino-2-(methylsulfanyl)-4-pyrimidinecarboxylic acid C6H7N3O2S 详情 详情
(III) 54680 6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-ol C7H6N4OS 详情 详情
(IV) 54681 8-chloro-2-(methylsulfanyl)pyrimido[5,4-d]pyrimidine; 8-chloropyrimido[5,4-d]pyrimidin-2-yl methyl sulfide C7H5ClN4S 详情 详情
(V) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VI) 54682 N-(3-chloro-4-fluorophenyl)-6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfanyl)pyrimido[5,4-d]pyrimidin-4-yl]amine C13H9ClFN5S 详情 详情
(VII) 54683 N-(3-chloro-4-fluorophenyl)-6-(methylsulfinyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfinyl)pyrimido[5,4-d]pyrimidin-4-yl]amine C13H9ClFN5OS 详情 详情
(VIII) 54684 N-(3-chloro-4-fluorophenyl)-6-(methylsulfonyl)pyrimido[5,4-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-[6-(methylsulfonyl)pyrimido[5,4-d]pyrimidin-4-yl]amine C13H9ClFN5O2S 详情 详情
(IX) 54685 1-methyl-4-piperidinamine; 1-methyl-4-piperidinylamine C6H14N2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VI)

The condensation of 3-ethoxy-4-nitroaniline (I) with 2-(ethoxymethylene)cyanacetic acid ethyl ester (II) in refluxing toluene gives the adduct (III), which is further cyclized in Dowtherm at 258 C to yield 7-ethoxy-6-nitro-4-oxo-1,4-dihydroquinoline-3-carbonitrile (IV). The reaction of (IV) with refluxing POCl3 affords the 4-chloroquinoline (V), which is condensed with 3-chloro-4-fluoroaniline (VI) in refluxing isopropanol to provide the secondary amine (VII). The reduction of the nitro group of (VII) with Fe and NH4Cl in refluxing methanol/water gives the corresponding amino derivative (VIII), which is condensed with the acid chloride (IX) by means of t-BuOCOCl and NMM in THF to yield the amide (X). Finally, this compound is treated with dimethylamine in THF to afford the target quinoline-3-carbonitrile.

1 Wissner, A.; Overbeek, E.; Reich, M.F.; Floyd, B.; Johnson, B.D.; Mamuya, N.; Rosfjord, E.C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S.K.; Gruber, B.C.; Ye, F.; Hallett, W.A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L.M.; Tsou, H.-R.; Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epi. J Med Chem 2003, 46, 1, 49.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61513 3-ethoxy-4-nitroaniline; 3-ethoxy-4-nitrophenylamine C8H10N2O3 详情 详情
(II) 61514 ethyl (Z)-2-cyano-3-propoxy-2-propenoate C9H13NO3 详情 详情
(III) 61515 ethyl (E)-2-cyano-3-(3-ethoxy-4-nitroanilino)-2-propenoate C14H15N3O5 详情 详情
(IV) 61516 7-ethoxy-6-nitro-4-oxo-1,4-dihydro-3-quinolinecarbonitrile C12H9N3O4 详情 详情
(V) 61517 4-chloro-7-ethoxy-6-nitro-3-quinolinecarbonitrile C12H8ClN3O3 详情 详情
(VI) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VII) 61518 4-(3-chloro-4-fluoroanilino)-7-ethoxy-6-nitro-3-quinolinecarbonitrile C18H12ClFN4O3 详情 详情
(VIII) 61519 6-amino-4-(3-chloro-4-fluoroanilino)-7-ethoxy-3-quinolinecarbonitrile C18H14ClFN4O 详情 详情
(IX) 50564 (E)-4-bromo-2-butenoyl chloride C4H4BrClO 详情 详情
(X) 61520 (E)-4-bromo-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-2-butenamide C22H17BrClFN4O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(V)

Condensation of cyano ester (I) with formamidine in the presence of NaOEt afforded the pyrimidinone derivative (II). Acetal hydrolysis of (II) with concomitant intramolecular cyclization under acidic conditions produced the pyrrolopyrimidinone (III), which was further chlorinated to (IV) in refluxing POCl3. Displacement of the 4-chloro of (IV) with 3-chloro-4-fluoroaniline (V) in the presence of silver triflate in hot DMF afforded the anilino pyrrolopyrimidine (VI). Oxidation of (VI) using pyridinium bromide perbromide furnished the alpha,alpha-dibromo lactam (VII). Reductive debromination of (VII) by means of zinc dust in AcOH gave intermediate (VIII).

1 Wei, C.C.; Tang, P.C.; McMahon, G.; Sun, L.; Hirth, K.P.; Liang, C.; Cui, J. (Sugen, Inc.); 4-Substd. 7-aza-indolin-2-ones and their use as protein kinase inhibitors. EP 1244672; WO 0146196 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14789 ethyl 2-cyano-4,4-diethoxybutanoate C11H19NO4 详情 详情
(II) 60644 2-[4-bromo-2-(2-fluorobenzoyl)anilino]-2-oxoethyl 4-methylbenzenesulfonate C22H17BrFNO5S 详情 详情
(III) 60045 3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one C6H5N3O 详情 详情
(IV) 60046 4-chloro-7H-pyrrolo[2,3-d]pyrimidine;6-Chloro-7-deazapurine;4-chloropyrrolo[2,3-d]pyrimidine;4-Chloro-1H-pyrrolo[2,3-d]pyrimidine 3680-69-1 C6H4ClN3 详情 详情
(V) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(VI) 60850 N-(3-chloro-4-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; N-(3-chloro-4-fluorophenyl)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine C12H8ClFN4 详情 详情
(VII) 60851 5,5-dibromo-4-(3-chloro-4-fluoroanilino)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one C12H6Br2ClFN4O 详情 详情
(VIII) 60852 4-(3-chloro-4-fluoroanilino)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one C12H8ClFN4O 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XIV)

Vilsmeier formylation of ethyl 4-methylpyrrole-2-carboxylate (VIII) affords aldehyde (IX). The ethyl ester group of (IX) is subsequently hydrolyzed under alkaline conditions to provide acid (X). Coupling of (X) with 4-(2-aminoethyl)morpholine (XI) gives amide (XII). Then, condensation between aldehyde (XII) and lactam (VII) in the presence of piperidine leads to adduct (XIII). The 4-chloro group of (XIII) is finally displaced with 3-chloro-4-fluoroaniline (XIV) in hot NMP to provide the title compound

1 Wei, C.C.; Tang, P.C.; McMahon, G.; Sun, L.; Hirth, K.P.; Liang, C.; Cui, J. (Sugen, Inc.); 4-Substd. 7-aza-indolin-2-ones and their use as protein kinase inhibitors. EP 1244672; WO 0146196 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII) 60048 4-chloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one C6H4ClN3O 详情 详情
(VIII) 60049 ethyl 4-methyl-1H-pyrrole-2-carboxylate C8H11NO2 详情 详情
(IX) 60050 ethyl 5-formyl-4-methyl-1H-pyrrole-2-carboxylate C9H11NO3 详情 详情
(X) 60051 5-formyl-4-methyl-1H-pyrrole-2-carboxylic acid C7H7NO3 详情 详情
(XI) 12880 4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide 2038-03-1 C6H14N2O 详情 详情
(XII) 59999 5-formyl-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide C13H19N3O3 详情 详情
(XIII) 59998 5-[(4-chloro-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-ylidene)methyl]-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide C19H21ClN6O3 详情 详情
(XIV) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线8

该中间体在本合成路线中的序号:(VIII)

 

1 Welham MJ.2005.Process for the manufacture。gefitinib. W0 2005023783(本专利为AstraZeneca plc所有)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 66436 (E)-N,N'-bis(3-chloro-4-fluorophenyl)formimidamide   C13H8Cl2F2N2 详情 详情
(VIII) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线9

该中间体在本合成路线中的序号:(X)

 

1 Jyothi Prasad R. 2005. An improved process for the preparation of gefitinib. WO2005023783(本专利为Natco Pharma Ltd所有)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 66437 4-methoxy-3-(3-morpholinopropoxy)benzaldehyde 861453-11-4 C15H21NO4 详情 详情
(III) 66438 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde   C15H20N2O6 详情 详情
(IV) 66439 (Z)-4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde oxime   C15H21N3O6 详情 详情
(V) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(VI) 66440 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzamide   C15H21N3O6 详情 详情
(VII) 66441 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide   C15H23N3O4 详情 详情
(VIII) 66442 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one   C16H21N3O4 详情 详情
(IX) 66443 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine   C16H20ClN3O3 详情 详情
(X) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线10

该中间体在本合成路线中的序号:(VIII)

 

1 Chandregowda V,Rao GV, Reddy GC. 2007. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4(3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles,71(1): 39~48
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 66437 4-methoxy-3-(3-morpholinopropoxy)benzaldehyde 861453-11-4 C15H21NO4 详情 详情
(IV) 66444 (Z)-4-methoxy-3-(3-morpholinopropoxy)benzaldehyde oxime   C15H22N2O4 详情 详情
(V) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(VI) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(VII) 66445 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one   C16H21N3O4 详情 详情
(VIII) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线11

该中间体在本合成路线中的序号:(IV)

 

1 Knesl P.Roeseling D,Jordis U 2006. Improved synthesis of substituted 6,7-rdihydroxy-4iuinazolinearninest: tandutinib, erlotinib and gefitinib. Molecules, 11(4):286~297
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65853 5-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one; 5-Hydroxy-7-methoxy-3H-quinazolin-4-one   C9H8N2O3 详情 详情
(II) 66446 7-methoxy-4-oxo-1,4-dihydroquinazolin-6-yl acetate   C11H10N2O4 详情 详情
(III) 18687 4-chloro-7-methoxy-6-quinazolinyl acetate 230955-75-6 C11H9ClN2O3 详情 详情
(IV) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(V) 66447 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate hydrochloride;6-Acetoxy-4-(3-chloro-4-fluoroanilino)-7-methoxyquinazoline hydrochloride  184475-70-5 C17H13ClFN3O3.HCl 详情 详情
(VI) 18690 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinol 184475-71-6 C15H11ClFN3O2 详情 详情
(VII) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情

合成路线12

该中间体在本合成路线中的序号:(IX)

 

1 Wang JQ, Gao MZ, Miller KD, et al.2006. Synthesis of (11 C) iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase. Bioorg Med Chem Lett, 16 (15): 4102~4106
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54574 3-hydroxy-4-methoxybenzonitrile 52805-46-6 C8H7NO2 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(IV) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(V) 66435 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile 675126-27-9 C15H21N3O3 详情 详情
(VI) 66441 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide   C15H23N3O4 详情 详情
(VII) 66445 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one   C16H21N3O4 详情 详情
(VIII) 66443 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine   C16H20ClN3O3 详情 详情
(IX) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(X) 66448 4-((3-chloro-4-fluorophenyl)amino)-6-(3-morpholinopropoxy)quinazolin-7-ol  847949-49-9 C21H22ClFN4O3 详情 详情

合成路线13

该中间体在本合成路线中的序号:(XIX)

The 7-methoxy-6-nitroquinazoline derivative (I) can be prepared by cyclization of 2-amino-4-fluorobenzoic acid (XIV) with formamidine acetate (XV) in 2-methoxyethanol to yield 7-fluoroquinazolin-4(3H)-one (XVI), which is then nitrated with HNO3 and H2SO4 to give 7-fluoro-6-nitroquinazolin-4(3H)-one (XVII) (1). Chlorination of quinazolinone (XVII) with SOCl2 at reflux provides 4-chloro-7-fluoro-6-nitroquinazoline (XVIII) , which is then coupled with 3-chloro-4-fluoroaniline (XIX) by means of Et3N or PhNMe2 in i-PrOH to produce the diarylamine (XX). Finally, fluoroquinazoline (XX) is treated with MeOH and NaH in .

1 Fakhoury, S.A., Lee, H.T., Reed, J.E., Schlosser, K.M., Sexton, K.E., Tecle, H., Winters, R.T. (Pfizer, Inc.). 4-Phenylamino-quinazolin-6-yl-amides. EP 1746999, JP 200753668, JP 2009007363, US 2005250761, US 7772243, WO 2005107758.
3 Bridges, A.J., Klohs, W.D., Driscoll, D. (Pfizer, Inc.). N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases. EP 1131304, JP 2002530386, US 6344455, WO 2000031048.
4 Smaill, J.B., Rewcastle, G.W., Loo, J.A. et al. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino) quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solublizing functions. J Med Chem 2000, 43(7): 1380-97.
2 Bridges, A.J., Horne, N.M., Jacks, T.E. et al. (Pfizer, Inc.). Preparation of substituted quinazolines. JP 2006517959, US 2004158065, WO 2004069791.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 68469 N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine   C15H10ClFN4O3 详情 详情
(XIV) 10805 2-Amino-4-fluorobenzoic acid 446-32-2 C7H6FNO2 详情 详情
(XV) 67709 formamidine acetate 3473-63-0 CH4N2.C2H4O2 详情 详情
(XVI) 19140 7-fluoro-4(3H)-quinazolinone C8H5FN2O 详情 详情
(XVII) 19141 7-fluoro-6-nitro-4(3H)-quinazolinone C8H4FN3O3 详情 详情
(XVIII) 19142 4-chloro-7-fluoro-6-nitroquinazoline C8H3ClFN3O2 详情 详情
(XIX) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(XX) 54956 N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-N-(7-fluoro-6-nitro-4-quinazolinyl)amine 162012-67-1 C14H7ClF2N4O2 详情 详情

合成路线14

该中间体在本合成路线中的序号:(XIX)

Compound (XIII) can be obtained by reductocondensation of 3-chloro-4-fluoroaniline (XIX) with 3,4-dimethoxybenzaldehyde (XXI) using NaCNBH3 or NaBH(OAc)3 in AcOH/i-PrOH to yield the benzylaniline derivative (XXII), which by condensation with 4-chloro-7-fluoro-6-nitroquinazoline (XVIII) in i-PrOH gives the tertiary amine (XXIII) . Substitution of fluoroquinazoline (XXIII) with NaOMe in refluxing MeOH affords the 7-methoxyquinazoline derivative (XXIV), which is reduced to the quinazoline-4,6-diamine (XXV) by means of H2 over Raney Ni in THF. Finally, compound (XXV) is coupled with 4-(piperidin-1-yl)-2-butenoyl chloride (IV) in DMA .
4-(Piperidin-1-yl)-2-butenoyl chloride (IV) can be prepared by condensation of methyl 4-bromocrotonate (XI) with piperidine (X) to yield methyl 4-(piperidin-1-yl)-2-butenoate (XXVI), which is then hydrolyzed with HCl to give 4-(piperidin-1-yl)-2-butenoic acid (XXVII). Finally, acid (XXVII) is reacted with (COCl)2 in the presence of DMF in CH2Cl2 .

1 Fakhoury, S.A., Lee, H.T., Reed, J.E., Schlosser, K.M., Sexton, K.E., Tecle, H., Winters, R.T. (Pfizer, Inc.). 4-Phenylamino-quinazolin-6-yl-amides. EP 1746999, JP 200753668, JP 2009007363, US 2005250761, US 7772243, WO 2005107758.
2 Bridges, A.J., Horne, N.M., Jacks, T.E. et al. (Pfizer, Inc.). Preparation of substituted quinazolines. JP 2006517959, US 2004158065, WO 2004069791.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXVI) 68482 (E)-methyl 4-(piperidin-1-yl)but-2-enoate   C10H17NO2 详情 详情
(IV) 68473 4-(piperidin-1-yl)-2-butenoyl chloride;(E)-4-(piperidin-1-yl)but-2-enoyl chloride   C9H14ClNO 详情 详情
(X) 10158 Piperidine 110-89-4 C5H11N 详情 详情
(XI) 26358 methyl (E)-4-bromo-2-butenoate 1117-71-1 C5H7BrO2 详情 详情
(XIII) 68477 (E)-N-(4-((3-chloro-4-fluorophenyl)(3,4-dimethoxybenzyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide   C33H35ClFN5O4 详情 详情
(XVIII) 19142 4-chloro-7-fluoro-6-nitroquinazoline C8H3ClFN3O2 详情 详情
(XIX) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情
(XXI) 18304 3,4-Dimethoxybenzaldehyde; Veratraldehyde 120-14-9 C9H10O3 详情 详情
(XXII) 68478 3-chloro-N-(3,4-dimethoxybenzyl)-4-fluoroaniline   C15NClFO2 详情 详情
(XXIII) 68479 N-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxybenzyl)-6-fluoro-7-nitroquinazolin-4-amine   C23H17ClF2N4O4 详情 详情
(XXIV) 68480 N-(3-chloro-4-fluorophenyl)-N-(3,4-dimethoxybenzyl)-6-methoxy-7-nitroquinazolin-4-amine   C24H20ClFN4O5 详情 详情
(XXV) 68481 N4-(3-chloro-4-fluorophenyl)-N4-(3,4-dimethoxybenzyl)-6-methoxyquinazoline-4,7-diamine   C24H22ClFN4O3 详情 详情
(XXVII) 26709 (E)-4-(1-piperidinyl)-2-butenoic acid;(E)-4-(piperidin-1-yl)but-2-enoic acid C9H15NO2 详情 详情
Extended Information